Solid Biosciences: A Strong Buy As An Emerging Biotech In The Gene Therapy Space
In our opinion, Solid Biosciences Inc. (NASDAQ: SLDB ) may be repositioning itself in a space that has very recently come under considerable scrutiny. Though still in early-stage trials, its lead candidate has shown encouraging results.IB's Thoughts is owned and operated by a stock market enthusiast, who has written for Seeking Alpha since 2014. IB's Thoughts is focused on identifying exciting investment opportunities, with a particular emphasis on healthcare.Analyst’s Disclosure: I/we have no stock, option ...